Vesalio
Clinical trials sponsored by Vesalio, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- One-Pass clot removal device tested in major stroke study Results expected Dec 2026 (estimated)
- New brain artery device under Real-World watch Results expected Feb 2027 (estimated)
-
New device aims to limit heart damage during heart attacks
Disease control OngoingThis study tests a new device called enVast that removes blood clots from heart arteries during a severe heart attack (STEMI). About 148 adults with large clots will either get standard care or standard care plus the enVast device. The goal is to see if the device reduces the siz…
Sponsor: Vesalio • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New stroke device shows promise in clearing brain blockages
Disease control OngoingThis study looked at 800 adults who had a stroke from a large blood clot in the brain. It compared a new device called the NeVa Stent Retriever to standard devices used to remove the clot. The goal was to see if the new device could restore blood flow better and with fewer side e…
Sponsor: Vesalio • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC